Dermatology

As cannabis products prove to be useful in treating some skin conditions, specialists are calling on clinicians to be aware of the barriers some patients face and suggest they keep up to date with both the science and legal sides of its use, according to a study.  The study, led by Samuel...

A biopharmaceutical company focused on the development of dermatology treatments saw a sharp drop after hours Thursday. What Happened: The clinical trial of Forte Biosciences (NASDAQ: FBRX) lead drug FB-401 failed to meet a statistical significance, the company said. Topline data from a Phase 2...

Ra Medical Systems Inc (NYSE: RMED) has sold its Pharos dermatology business to STRATA Skin Sciences Inc (NASDAQ: SSKN) for $3.7 million in cash.  The Pharos excimer laser is an FDA-cleared treatment for psoriasis, vitiligo, atopic dermatitis, and leukoderma. "We believe...

Fortress Biotech Inc's (NASDAQ: FBIO) partner company Journey Medical Corporation has agreed to acquire Qbrexza (glycopyrronium) in the U.S. from Dermira Inc, a wholly-owned subsidiary of Eli Lilly And Co (NYSE: LLY). The transaction is...

Sonoma Pharmaceuticals Inc (NASDAQ: SNOA) has entered into an agreement with EMC Pharma LLC for the exclusive right to manage, market, and distribute Sonoma's HOCl-based prescription dermatology and eye care products in the U.S. for an initial term of five years, subject to...

Investors who bought into Verrica Pharmaceuticals Inc (NASDAQ: VRCA) at its June 15 IPO are celebrating 13.1-percent returns. The gains should continue, in the view of two new sell-side bulls. The Ratings Bank of America Merrill Lynch analyst Jason Gerberry initiated coverage of Verrica with a Buy...

Strata Skin Sciences, Inc. (NASDAQ: SSKN), a nano-cap medical technology company that develops, commercializes and markets innovative products for the treatment of dermatologic conditions, has a more than 400 percent upside, according to HC Wainwright & Co's Joseph Pantginis. Pantginis...